US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Research & Development Market Research Reports & Industry Analysis

The term research and development (R&D) refers to work that is done in order to better understand the nature, function or understanding of a topic or product in order to gain knowledge and find new applications for existing products or to develop new and innovative products. This is usually performed by corporations, government agencies, and research or academic institutions.

New product design and development is essential for the survival and growth of many companies, as markets and consumers’ tastes are fickle and the competition can be fierce. In order to stay relevant in a fast changing marketplace, firms have to constantly revise and expand their range of product offerings. Therefore, research and development is of great economic importance as companies fight to maintain their market share, though it may mean forgoing current profits in favor of potential future performance and returns.

Research and development is most often associated with the technology industry, as well as with science and in particular with healthcare and the development of new pharmaceuticals, diagnostics or medical devices that are safe and effective. For instance, drug makers must constantly search for the next big blockbuster drug, since the products they currently have on the market will eventually lose their patent protection and be vulnerable to generic competition. So they spend huge amounts of money on R&D because without a promising drug pipeline their revenue stream will ultimately dry up.

RSS Feeds

Research & Development Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2025
7/27/2016 | published by: Kalorama Information
... major companies. This report provides long-term company sales forecasts based recent market conditions. For each company covered, the report provides: Corporate Summary Total Company Revenue and Total R&D Spending 2011-2015 Break-up of Sales by Region, ...  |  read more...
USD 3,500
Target Atlas in Breast Cancer: A Competitive Outlook
8/9/2016 | published by: BioSeeker Group AB
... Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Breast Cancer: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, ...  |  read more...
USD 6,750
Target Atlas in Prostate Cancer: A Competitive Outlook
8/9/2016 | published by: BioSeeker Group AB
... Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Prostate Cancer: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, ...  |  read more...
USD 6,750
Target Atlas in Colorectal Cancer: A Competitive Outlook
8/9/2016 | published by: BioSeeker Group AB
... Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Colorectal Cancer: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, ...  |  read more...
USD 6,750
Non-Insulin Therapies for Diabetes: GLP-1 Agonists, DPP4 Inhibitors and SGLT2 Inhibitors, 2016 - 2026
8/11/2016 | published by: Roots Analysis
... the US. The increasing incidence, growing prevalence and the progressive nature of the disease has spurred several pharmaceutical companies to develop novel approaches / therapies to provide better treatment options for diabetic patients worldwide. While ...  |  read more...
USD 2,349
Target Atlas in Ovarian Cancer: A Competitive Outlook
8/9/2016 | published by: BioSeeker Group AB
... Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Ovarian Cancer: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, ...  |  read more...
USD 6,750
Target Atlas in Liver Cancer: A Competitive Outlook
8/9/2016 | published by: BioSeeker Group AB
... Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Liver Cancer: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, ...  |  read more...
USD 4,485
Target Atlas in Hematological Cancers: A Competitive Outlook
8/9/2016 | published by: BioSeeker Group AB
... Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Hematological Cancers: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, ...  |  read more...
USD 8,850
Pancreatic Beta-Cell Protection - Hot Targets & Pipeline Analysis
8/12/2016 | published by: IQ4I Research and Consultancy
... beta-cell protection in both Type-1 diabetes & Type-2 diabetes disease progression. This report enables Pharmaceutical /Biotech companies, Academic institutes, Individual researchers, Investors, Medical technology companies, Service providers and other associated stake holders to identify and ...  |  read more...
USD 3,600
Late Stage Drugs (Phase III) in Oncology: Analytical Tool
8/22/2016 | published by: BioSeeker Group AB
... biotech/pharma professionals from a business development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & ...  |  read more...
USD 20,250
Target Atlas in Pancreatic Cancer: A Competitive Outlook
8/9/2016 | published by: BioSeeker Group AB
... Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Pancreatic Cancer: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, ...  |  read more...
USD 6,750
Target Atlas in Lung Cancer: A Competitive Outlook
8/9/2016 | published by: BioSeeker Group AB
... Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Lung Cancer: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, ...  |  read more...
USD 6,750
Target Atlas in Bladder Cancer: A Competitive Outlook
8/9/2016 | published by: BioSeeker Group AB
... Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Bladder Cancer: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, ...  |  read more...
USD 6,750
Target Atlas in Brain Cancer: A Competitive Outlook
8/9/2016 | published by: BioSeeker Group AB
... Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Brain Cancer: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, ...  |  read more...
USD 6,750
Target Atlas in Neuroendocrine Tumors: A Competitive Outlook
8/9/2016 | published by: BioSeeker Group AB
... Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Neuroendocrine Tumors: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, ...  |  read more...
USD 4,485
Target Atlas in Head and Neck Cancer: A Competitive Outlook
8/9/2016 | published by: BioSeeker Group AB
... cancer by identifying the most promising Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Head and Neck Cancer: A Competitive ...  |  read more...
USD 6,750
Target Atlas in Leukemia: A Competitive Outlook
8/9/2016 | published by: BioSeeker Group AB
... development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Leukemia: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, integrated with drug pipeline ...  |  read more...
USD 6,750
Target Atlas in Lymphoma: A Competitive Outlook
8/9/2016 | published by: BioSeeker Group AB
... development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Lymphoma: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, integrated with drug pipeline ...  |  read more...
USD 6,750
Proof-of-Concept (Phase II) Drugs in Oncology: Analytical Tool
8/22/2016 | published by: BioSeeker Group AB
... professionals from a business development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & Late ...  |  read more...
USD 20,250
Target Atlas in Melanoma: A Competitive Outlook
8/9/2016 | published by: BioSeeker Group AB
... development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Melanoma: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, integrated with drug pipeline ...  |  read more...
USD 6,750
Target Atlas in Peritoneal Cancer: A Competitive Outlook
8/9/2016 | published by: BioSeeker Group AB
... Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Peritoneal Cancer: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, ...  |  read more...
USD 6,750
Clinical Research (UK) - Industry Report
8/1/2016 | published by: Plimsoll Publishing Ltd.
... LTD and HAMMERSMITH MEDICINES RESEARCH LTD. This report covers activities such as clinical trials, cro, biotechnology, clinical research, pharmaceutical development and includes a wealth of information on the financial trends over the past four years. ...  |  read more...
USD 550
Medical & Scientific Research (GLOBAL) - Industry Report
8/1/2016 | published by: Plimsoll Publishing Ltd.
... CORP, QUINTILES LIMITED and WEBASTO DONGHEE HOLDINGS CO.,LTD.. This report includes a wealth of information on the financial trends over the past four years. Plimsoll Publishing’s latest Medical & Scientific Research (GLOBAL) analysis is ideal ...  |  read more...
USD 1,480
Medical & Scientific Research (GLOBAL) - Industry Report
8/1/2016 | published by: Plimsoll Publishing Ltd.
... BRACCO IMAGING S.P.A. and TEXAS INSTRUMENTS FRANCE. This report includes a wealth of information on the financial trends over the past four years. Plimsoll Publishing’s latest Medical & Scientific Research (GLOBAL) analysis is ideal for ...  |  read more...
USD 1,480
Breast Cancer Drug Pipeline Update
8/4/2016 | published by: BioSeeker Group AB
... metastatic setting, the overall survival remains below five years. There are today 636 companies plus partners developing 706 drugs targeting breast cancer in development. In addition, there are 7 suspended drugs and the accumulated number ...  |  read more...
USD 6,750
< prev 1    3  4  5  6  7  8  9  10